Recent News

18/01/17

Telix Pharmaceuticals takes an exclusive purchase option for the acquisition of Atlab Pharma

Telix Pharmaceuticals and Atlab Pharma conclude therapeutic product development agreement for prostate cancer. Telix website (EN) Press release (EN) :... Read More →
15/11/16

Linda Evangelista Appointed as New Creative Director for ERASA XEP-30

BioMimetic Laboratories’ revolutionary skincare product adds fashion and beauty icon to product innovation and brand management team. Elle.com coverage (EN)... Read More →
06/09/16

OGD2 Pharma and Syndivia launch collaboration to develop an Antibody-Drug Conjugate (ADC) targeting the O-acetyl-GD2 cancer antigen

A few months after announcing its collaboration with the Korean pharmaceutical company GreenCross in cell therapy, OGD2 Pharma is getting... Read More →

Why Choose Us?

Team up with us, we hold a successful track record in Health & Beauty, and bring our expertise at every step of your development.

Get in touch

Invest in us, we are bringing a handful of exciting innovations to the market and focus on building long-term, trustworthy relationships.

Get in touch

Co-invest with us, we look for relevant partners to join forces and broaden the scope of our investments to growth capital opportunities.

Get in touch

Some of our holdings:

 

Back to Top